Suture Anchor Devices Market
By Product Type;
Absorbable and Non-AbsorbableBy Tying Type;
Knotted Suture Anchors and KnotlessBy Material Type;
Metallic Suture Anchor, Bio-Absorbable Suture Anchor, PEEK Suture Anchor, Bio-Composite Suture Anchor, and All Suture AnchorBy End User;
Hospitals, Emergency Medical Services, Clinics, and Ambulatory Surgical CentresBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Suture Anchor Devices Market Overview
Suture Anchor Devices Market (USD Million)
Suture Anchor Devices Market was valued at USD 666.31 million in the year 2024. The size of this market is expected to increase to USD 918.97 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.
Suture Anchor Devices Market
*Market size in USD million
CAGR 4.7 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 4.7 % |
Market Size (2024) | USD 666.31 Million |
Market Size (2031) | USD 918.97 Million |
Market Concentration | High |
Report Pages | 326 |
Major Players
- Smith & Nephew plc
- Zimmer Biomet Holdings Inc
- ConMed Corporation
- Arthrex Inc
- Johnson and Johnson (DePuy Synthes, Inc.)
- Medtronic plc
- Stryker Corporation
- Parcus Medical LLC
- Anika Therapeutics
- Stryker
- OSSIO
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Suture Anchor Devices Market
Fragmented - Highly competitive market without dominant players
The Suture Anchor Devices Market is experiencing robust growth as orthopedic surgeons and sports medicine specialists increasingly adopt high-strength implant anchors for tendon and ligament repair. Nearly 65% of repair procedures now use bioabsorbable or all‑suture anchors to ensure secure fixation. This uptick is driving innovation and market expansion, supported by collaboration between clinical experts and medical device engineers.
Anchor Design Enhancing Surgical Precision
Around 62% of manufacturers are rolling out anchors with advancements such as dual‑load suturing capability, polymer–metal hybrid structures, biodegradable materials, and color‑coded sizing. These technological advancements enhance fixation strength and surgical efficiency. Joint efforts between surgeons and R&D teams are accelerating improved anchor design.
Clinical Programs Boosting Adoption Rates
Collaborative clinical studies and adoption programs involving orthopedic hospitals, device innovators, and surgical training centers have resulted in a 59% increase in utilization of advanced anchor systems. These cross-functional collaborations ensure anatomically precise placement techniques, surgeon certification, and outcome monitoring—driving growth through procedural excellence.
Next‑Gen Anchor Technology Leading Surgical Evolution
Looking forward, over 70% of next-generation anchor devices are expected to incorporate smart suture tracking, integrated tension sensors, and bioactive surface coatings promoting tissue integration. These innovations mark a shift toward adaptive surgical fixation solutions, enabling real‑time feedback, enhanced healing, and reduced revision rates.
Suture Anchor Devices Market Recent Developments
-
In September 2023, at the 2023 Orthopaedic Summit (OSET) Annual Meeting, Anika Therapeutics, Inc. announced the launch of their RevoMotion Reverse Shoulder Arthroplasty System (RSA). The company also showcased the Integrity Implant System and the X-Twist Fixation System at the event. Anika's advanced shoulder portfolio, which includes the recently introduced X-Twist suture anchors, aligns with the increasing demand for suture anchor devices in the orthopedic market
-
In December 2022 , Stryker launched Citrefix, a suture anchor system for ankle and foot surgical procedures, leveraging Citregen biomaterial that is designed to support bone regeneration and the natural healing process. Citregen, a bioresorbable substance, has been designed to emulate native bone structure and chemistry
-
In August 2022 , OSSIO launched and commercially released its OSSIOfiber suture anchors in the U.S. for the first time. These anchors received FDA clearance for soft tissue to bone fixation in various areas of the body.
Suture Anchor Devices Market Segment Analysis
In this report, the Suture Anchor Devices Market has been segmented by Product Type, Tying Type, Material Type, End User, and Geography.
Suture Anchor Devices Market, Segmentation by Product Type
The Suture Anchor Devices Market has been segmented by Product Type into Absorbable and Non-Absorbable.
Absorbable
Absorbable suture anchors accounted for nearly 46 – 47 % of the global suture anchor devices market in 2024. They are increasingly popular due to their ability to naturally degrade, avoiding surgical removal and minimizing long‑term implant‑related complications. This segment is the fastest‑growing, with projected CAGRs of about 8 % through 2030. Supported by innovations in bio‑polymers and the rise of arthroscopic soft‑tissue procedures, absorbable anchors are gaining traction in sports medicine and minimally invasive orthopedic surgeries.
Non‑Absorbable
Non‑absorbable suture anchors continued to lead the market with over 53 % share in 2024, driven by their exceptional mechanical strength and durable fixation in demanding orthopedic applications. While growth is steadier at around 3.5 – 4.5 % annually, these anchors remain essential for procedures requiring long‑term stability—such as tendon and ligament repairs. Advanced substances like PEEK and titanium offer compatibility with imaging and improve clinical reliability, reinforcing their dominance in surgical settings.
Suture Anchor Devices Market, Segmentation by Tying Type
The Suture Anchor Devices Market has been segmented by Tying Type into Knotted Suture Anchors and Knotless.
Knotless Suture Anchors
Knotless suture anchors captured roughly 44–56 % of the global suture anchor devices market in 2024. These anchors simplify surgical workflows by eliminating knot tying, delivering uniform tension, reducing operation time, and enhancing tissue protection. Clinical research has also shown that knotless systems result in lower soft‑tissue irritation and streamline postoperative recovery—making them the preferred choice for arthroscopic and minimally invasive procedures.
Knotted Suture Anchors
Knotted suture anchors accounted for approximately 40–56 % share in 2024, offering surgeons the ability to fine‑tune tension intraoperatively—especially valuable in demanding tendon and ligament repairs. While typically more affordable, these systems require longer surgical time and can create knot bulk, which may lead to postoperative discomfort. As clinical teams prioritize efficiency, knotted anchors remain in use where precision and cost‑control outweigh speed advantages.
Suture Anchor Devices Market, Segmentation by Material Type
The Suture Anchor Devices Market has been segmented by Material Type into Metallic Suture Anchor, Bio-Absorbable Suture Anchor, PEEK Suture Anchor, Bio-Composite Suture Anchor and All Suture Anchor.
Metallic Suture Anchor
Metallic suture anchors continue to serve niche surgical roles, particularly in high-load-bearing revisions and trauma settings, thanks to their unmatched mechanical strength and minimal anchor displacement. Though less favored in MRI-sensitive scenarios, they maintain clinical relevance where permanent fixation is essential.
Bio‑Absorbable Suture Anchor
Bio-absorbable suture anchors offer the advantage of gradual resorption, eliminating long-term implant retention and minimizing imaging artifacts. As of 2024, they likely accounted for around one-quarter to one-third of the material-based market, with projected CAGR of ≈8.15 % through 2030 driven by regulatory gains and improved biomaterial performance.
PEEK Suture Anchor
PEEK anchors dominated the material segment in 2024 with approximately 35.5 % market share. They deliver bone-like strength, radiolucency compatible with CT/MRI, and consistent durability—especially in shoulder and hip arthroscopies—making them a surgeon-favorite for mid to long-term fixation needs.
Bio‑Composite Suture Anchor
Bio-composite anchors are estimated to have captured about 50.4 % of revenue by 2025, indicating dominance in the material category. They combine bioactive ceramics with polymers to enable bone integration and minimize inflammatory response, driving rapid clinical adoption and revenue growth.
All Suture Anchor
All-suture anchors, composed entirely of soft materials, occupy a growing share of the “others” category. Appreciated for requiring minimal drill size, offering a low implant profile, and delivering high stiffness, these anchors are gaining traction where bone preservation and minimal tissue disruption are priorities.
Suture Anchor Devices Market, Segmentation by End User
Hospitals
Hospitals commanded around 67.7 % of the global suture anchor devices market in 2024. Their dominance stems from high surgical volumes—including procedures like tendon and ligament repairs—and access to cutting-edge anchor technology. With built-in surgical infrastructure and strong demand for advanced fixation systems, hospitals continue as the primary anchor purchasers.
Ambulatory Surgical Centres
ASCs comprised approximately 24.8 % of global market revenue in 2024 and are projected to grow fastest, with a ~10.2 % CAGR through 2030. Favored for minimally invasive outpatient orthopedic surgeries, ASCs offer efficient care delivery and faster recovery timelines, fueling their rapid adoption.
Clinics
Orthopedic clinics, often merged with hospital data, play a pivotal role in the ~67.7 % share. Focused on musculoskeletal care, they deliver customized treatments with emphasis on value, patient convenience, and procedure‑specific protocols.
Emergency Medical Services (EMS)/Other End Users
EMS support services, minor procedure units, and mobile surgical setups represent the remaining ~7–8 % of market usage. While smaller in scale, they are vital in delivering urgent or trauma-related soft‑tissue repairs, particularly in remote or emergency settings.
Suture Anchor Devices Market, Segmentation by Geography
In this report, the Suture Anchor Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Suture Anchor Devices Market Share (%), by Geographical Region
North America
North America led the suture anchor devices industry in 2024 with roughly 41–42.5 % market share. Its dominance is driven by high rates of orthopedic surgeries, especially sports injury treatments, world-class healthcare infrastructure, and early uptake of innovative anchor solutions.
Europe
Europe ranked second globally in 2024 with nearly 25 % share, supported by demographic trends such as an aging population and increasing musculoskeletal disorders. Strong demand in sports medicine and regulatory support further sustain anchor utilization.
Asia Pacific
Asia Pacific held about 24.9 % of market revenue in 2024 and is expected to deliver the fastest regional growth, with a projected ~4.6 % CAGR through 2030. Healthcare modernization, increasing surgery volumes from sports injury and degenerative conditions, and expansion in China and India drive this growth.
Middle East and Africa
MEA made up under 5 % of the global market in 2024, representing a smaller regional share but gradually growing. Investments in healthcare infrastructure, especially in GCC countries, are expanding access to orthopedic interventions.
Latin America
Latin America accounted for approximately 5 % of global market revenue in 2024. Although penetration remains modest, adoption is increasing, particularly in Brazil and Mexico, where minimally invasive orthopedic techniques are becoming more prevalent.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Suture Anchor Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Ligament reconstruction
- Biomechanical properties
- Healthcare infrastructure
-
Healthcare expenditure -The global suture anchor devices market is closely tied to healthcare expenditure trends worldwide. As healthcare expenditure increases, there is typically a corresponding rise in demand for medical devices and technologies, including suture anchor devices. Healthcare expenditure encompasses a broad range of categories, including hospital services, physician services, pharmaceuticals, and medical devices.
Several factors contribute to the growth of healthcare expenditure, such as population aging, the prevalence of chronic diseases, advancements in medical technology, and increasing access to healthcare services. In developed countries with aging populations, there is often greater demand for surgical interventions, including orthopedic and cardiovascular procedures that utilize suture anchor devices. Additionally, the adoption of innovative and minimally invasive surgical techniques drives the demand for advanced medical devices, further propelling healthcare expenditure.
In emerging economies, rising disposable incomes, expanding healthcare infrastructure, and government initiatives to improve healthcare access contribute to increased healthcare spending. As these countries invest in upgrading their healthcare systems and expanding coverage, there is a growing demand for medical devices, including suture anchor devices, to meet the needs of a larger patient population.
The relationship between healthcare expenditure and the suture anchor devices market underscores the importance of understanding healthcare economics and policy trends when analyzing market dynamics. Companies operating in the suture anchor devices market closely monitor healthcare expenditure patterns to identify growth opportunities, allocate resources effectively, and develop strategies to capitalize on evolving market trends. Overall, healthcare expenditure serves as a key driver of market growth and plays a pivotal role in shaping the landscape of the global suture anchor devices market.
Restraints
- Product recalls or quality issues
- Healthcare budget constraints
- Reimbursement issues
-
Supply chain disruptions -The global suture anchor devices market, like many other sectors, has faced challenges due to supply chain disruptions. These disruptions can arise from various factors such as transportation restrictions, raw material shortages, labor issues, and geopolitical tensions. The COVID-19 pandemic, in particular, has exacerbated existing supply chain vulnerabilities, leading to delays in manufacturing, distribution, and procurement of suture anchor devices.
One significant impact of supply chain disruptions is the shortage of essential raw materials required for manufacturing suture anchor devices. For instance, disruptions in the production of polymers or metals used in anchor construction can lead to supply shortages and increased production costs. Manufacturers may struggle to procure these materials in sufficient quantities, resulting in delays in product availability and increased prices for healthcare providers and patients.
Transportation disruptions, including border closures, reduced air freight capacity, and port congestion, have hampered the timely delivery of suture anchor devices to end-users. This can lead to inventory shortages, longer lead times, and logistical challenges for manufacturers and distributors. Healthcare facilities may experience difficulties in accessing critical medical supplies, impacting patient care and surgical procedures.
Labor shortages and workforce disruptions further compound supply chain challenges in the suture anchor devices market. Factory closures, reduced staffing levels, and safety protocols implemented to mitigate the spread of COVID-19 can disrupt production schedules and hinder operational efficiency. Manufacturers may struggle to meet demand, leading to backlogs and delays in fulfilling orders.
Geopolitical tensions and trade disputes can also disrupt the supply chain for suture anchor devices by imposing tariffs, export restrictions, or sanctions on key manufacturing regions. These geopolitical factors introduce uncertainty and risk into the supply chain, affecting market dynamics and pricing strategies.
The impact of supply chain disruptions, stakeholders in the suture anchor devices market are exploring strategies such as diversifying sourcing locations, strengthening supplier relationships, and implementing contingency plans. Collaboration between manufacturers, distributors, and regulatory authorities is essential to address challenges effectively and ensure the continued availability of suture anchor devices for patients worldwide. Additionally, investments in digitalization, predictive analytics, and resilient supply chain infrastructure can enhance agility and responsiveness in managing future disruptions.
Opportunities
- Aging Population
- Next-Generation Designs
- Biomechanical Improvements
-
Enhanced Surgical Outcomes -The global suture anchor devices market plays a crucial role in enhancing surgical outcomes across a spectrum of medical procedures. These innovative devices provide surgeons with reliable tools for securing soft tissue to bone, facilitating effective repair and reconstruction in orthopedic, sports medicine, and other surgical disciplines.
One of the key ways in which suture anchor devices contribute to enhanced surgical outcomes is by improving fixation strength and stability. By securely anchoring soft tissue to bone, these devices help maintain proper alignment and tension, promoting optimal healing and reducing the risk of complications such as re-tears or loosening of repaired tissues.
Suture anchor devices support minimally invasive surgical techniques, enabling surgeons to perform procedures with smaller incisions and reduced tissue trauma. This approach leads to faster recovery times, decreased post-operative pain, and improved patient satisfaction compared to traditional open surgeries.
The versatility of suture anchor devices further enhances surgical outcomes by accommodating a wide range of procedures and patient anatomies. Surgeons can choose from various types of anchors, including knotted and knotless options, as well as different materials and sizes to suit the specific needs of each case.
Advancements in suture anchor technology continue to drive improvements in surgical precision and efficiency. Innovations such as pre-loaded anchors, self-punching anchors, and bioabsorbable materials enhance ease of use while minimizing surgical time and complexity.
Competitive Landscape Analysis
Key players in Global Suture Anchor Devices Market include.
- Smith & Nephew plc
- Zimmer Biomet Holdings Inc
- ConMed Corporation
- Arthrex Inc
- Johnson and Johnson (DePuy Synthes, Inc.)
- Medtronic plc
- Stryker Corporation
- Parcus Medical LLC
- Anika Therapeutics
- Stryker
- OSSIO
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Tying Type
- Market Snapshot, By Material Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Suture Anchor Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Ligament reconstruction
-
Biomechanical properties
-
Healthcare infrastructure
-
Healthcare expenditure
-
- Restraints
-
Product recalls or quality issues
-
Healthcare budget constraints
-
Reimbursement issues
-
Supply chain disruptions
-
- Opportunities
-
Aging Population
-
Next-Generation Designs
-
Biomechanical Improvements
-
Enhanced Surgical Outcomes
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Suture Anchor Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Absorbable
- Non-Absorbable
- Suture Anchor Devices Market, By Tying Type, 2021 - 2031 (USD Million)
- Knotted Suture Anchors
- Knotless
- Suture Anchor Devices Market, By Material Type, 2021 - 2031 (USD Million)
- Metallic Suture Anchor
- Bio-Absorbable Suture Anchor
- PEEK Suture Anchor
- Bio-Composite Suture Anchor
- All Suture Anchor
- Suture Anchor Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Emergency Medical Services
- Clinics
- Ambulatory Surgical Centres
- Suture Anchor Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Suture Anchor Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Smith & Nephew plc
- Zimmer Biomet Holdings Inc
- ConMed Corporation
- Arthrex Inc
- Johnson and Johnson (DePuy Synthes Inc)
- Medtronic plc
- Stryker Corporation
- Parcus Medical LLC
- Anika Therapeutics
- Stryker
- OSSIO
- Company Profiles
- Analyst Views
- Future Outlook of the Market